Literature DB >> 11456277

A patient with type 1 diabetes mellitus and cerebellar ataxia associated with high titer of circulating anti-glutamic acid decarboxylase antibodies.

H Iwasaki1, R Sato, M Shichiri, Y Hirata.   

Abstract

A 66-year-old Japanese woman presenting with recent onset of type 1 diabetes mellitus and cerebellar ataxia was admitted to our hospital. Physical examination on admission revealed coordinate disturbance due to cerebellar ataxia, and the laboratory examination showed marked hyperglycemia with ketosis and impaired insulin secretion. Anti-glutamic acid decarboxylase (GAD) antibodies in high titer were detected in patient's serum. Immunoblotting showed the patient's serum reacted with a 65 kDa protein in tissue extracts from rat pancreas and cerebellum, and immunohistochemical study produced positive immunostaining in the pancreatic islets of Langerhans, the axons of Purkinje cells and the nerve terminals in the granular layers of cerebellum of the rat. This is the first case presenting with concomitant type 1 diabetes and cerebellar ataxi associated with high titers of circulating anti-GAD antibodies which may play a critical role in the development of the diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11456277     DOI: 10.1507/endocrj.48.261

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  8 in total

1.  High levels of Anti-GAD65 and Anti-Ro52 autoantibodies in a patient with major depressive disorder showing psychomotor disturbance.

Authors:  Kathryn H Ching; Peter D Burbelo; Paul J Carlson; Wayne C Drevets; Michael J Iadarola
Journal:  J Neuroimmunol       Date:  2010-03-12       Impact factor: 3.478

2.  Long-lived plasma cells and memory B cells produce pathogenic anti-GAD65 autoantibodies in Stiff Person Syndrome.

Authors:  Marta Rizzi; Rolf Knoth; Christiane S Hampe; Peter Lorenz; Marie-Lise Gougeon; Brigitte Lemercier; Nils Venhoff; Francesca Ferrera; Ulrich Salzer; Hans-Jürgen Thiesen; Hans-Hartmut Peter; Ulrich A Walker; Hermann Eibel
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

3.  High definition profiling of autoantibodies to glutamic acid decarboxylases GAD65/GAD67 in stiff-person syndrome.

Authors:  Peter D Burbelo; Sandra Groot; Marinos C Dalakas; Michael J Iadarola
Journal:  Biochem Biophys Res Commun       Date:  2007-11-29       Impact factor: 3.575

4.  A 70-year-old male with peripheral neuropathy, ataxia and antigliadin antibodies shows improvement in neuropathy, but not ataxia, after intravenous immunoglobulin and gluten-free diet.

Authors:  Dharshan Anandacoomaraswamy; Jagdeesh Ullal; Aaron I Vinik
Journal:  J Multidiscip Healthc       Date:  2008-10-01

5.  The ER retention protein RER1 promotes alpha-synuclein degradation via the proteasome.

Authors:  Hyo-Jin Park; Daniel Ryu; Mayur Parmar; Benoit I Giasson; Nikolaus R McFarland
Journal:  PLoS One       Date:  2017-09-06       Impact factor: 3.240

Review 6.  Pathogenic Roles of Glutamic Acid Decarboxylase 65 Autoantibodies in Cerebellar Ataxias.

Authors:  Hiroshi Mitoma; Mario Manto; Christiane S Hampe
Journal:  J Immunol Res       Date:  2017-03-12       Impact factor: 4.818

7.  Anti-glutamate Dehydrogenase Antibody Positive Cerebellar Ataxia and Stiff Person Syndrome Responding to Dual Treatment with Steroids and Intravenous Immunoglobulin: A Case Presentation and Literature Review.

Authors:  Furkan M Yilmaz; Dena Little; Micheal Gallagher; Amy Colcher
Journal:  Cureus       Date:  2019-06-06

Review 8.  GAD antibody-spectrum disorders: progress in clinical phenotypes, immunopathogenesis and therapeutic interventions.

Authors:  Popianna Tsiortou; Harry Alexopoulos; Marinos C Dalakas
Journal:  Ther Adv Neurol Disord       Date:  2021-03-30       Impact factor: 6.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.